Sign in

CIK 0000943819

  • Large accelerated filer
Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
980152841
Phone
+1 858-746-2400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,744,605
in 5 filings, $3.7M under 10b5-1 plans

Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-15 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 122,640
2022-02-15 Douglas Robert Andrew President and COO Option exercise +8,000 $58.24 $466K 25,175
2022-02-15 Douglas Robert Andrew President and COO Sale −8,000 $235.81 $1.9M 17,175
2022-02-15 Douglas Robert Andrew President and COO Option exercise · ResMed Common Stock Options −8,000 70,098
2022-02-10 Sandercock Brett Chief Financial Officer Option exercise +2,500 $57.76 $144K 108,854
2022-02-10 Sandercock Brett Chief Financial Officer Sale −2,500 $241.86 $605K 106,354
2022-02-10 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options −2,500 15,000
2022-02-03 PENDARVIS DAVID Chief Administration Officer Sale −1,544 $232.87 $360K 114,491
2022-01-18 Douglas Robert Andrew President and COO Option exercise +8,000 $58.24 $466K 25,175
2022-01-18 Douglas Robert Andrew President and COO Sale −8,000 $247.80 $2.0M 17,175
2022-01-18 Douglas Robert Andrew President and COO Option exercise · ResMed Common Stock Options −8,000 78,098
2022-01-18 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 410,904
2022-01-18 Farrell Michael J. Chief Executive Officer Sale −5,675 $241.94 $1.4M 405,229
2022-01-18 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 128,315
2022-01-10 Sandercock Brett Chief Financial Officer Option exercise +2,500 $57.76 $144K 108,854
2022-01-10 Sandercock Brett Chief Financial Officer Sale −2,500 $235.00 $588K 106,354
2022-01-10 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options −2,500 17,500
2022-01-03 PENDARVIS DAVID Chief Administration Officer Sale −1,544 $258.52 $399K 116,035
2021-12-31 Leong Justin President, Asia Latin America Shares withheld for taxes −562 $259.47 $146K 49,295
2021-12-15 Douglas Robert Andrew President and COO Option exercise +8,000 $58.24 $466K 25,175

Page 29 of 37 · 721 trades